A comment on metformin and COVID-19 with regard to "Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID-19 patients with diabetes: A population-based study in Lombardy"

Diabetes Obes Metab. 2022 Sep;24(9):1888-1893. doi: 10.1111/dom.14746. Epub 2022 May 25.

Abdallah Al-Salameh^{1

2}, Nicolas Wiernsperger³, Bertrand Cariou⁴, Jean-Daniel Lalau^{1

2}

¹ Department of Endocrinology-Diabetes Mellitus and Nutrition, Amiens University Hospital, Amiens, France.
² PériTox, UMR-I 01, University of Picardie Jules Verne, Amiens, France.
³ Association REMEDES, Ville-sur-Jarnioux, France.
⁴ Département d'Endocrinologie, Diabétologie et Nutrition, l'institut du thorax, Inserm, CNRS, UNIV Nantes, CHU Nantes, Hôpital Guillaume et René Laennec, Nantes Cedex 01, France.

No abstract available

Publication types